Conditions: In Vitro Fertilization
Keywords: Luteal support in IVF
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 800
Healthy volunteers: no

Brief summary:
Prospective, open, randomized, parallel, multicenter, two-arm trial to evaluate the efficacy and tolerability of a new progesterone formulation to be used for luteal support in IVF (Progesterone-IBSA) administered subcutaneously at a daily dose of 25 mg versus Progesterone tablets administered intravaginally at 100 mg twice daily for a total dose of 200 mg.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Progesterone intervention 2: Progesterone
Intervention descriptions: intervention 1: 25 mg, once a day, SC intervention 2: 100 mg, twice a day, vaginally

Protocol document: